A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)–Ru(II) Anticancer Prodrug

Abstract

Although different types of metal-based anticancer complexes have been synthesized, novel complexes to reduce the serious side effect of cisplatin and conquer cancer metastasis are still highly desired. Here, we report the synthesis, characterization, and biological activity of a novel heterodinuclear Pt(IV)-Ru(II) anticancer prodrug. The Pt(IV)-Ru(II) complex exhibits good stability in both water and PBS solution. Biological evaluation revealed that this bifunctional Pt(IV)-Ru(II) complex utilizes the advantages of two metal centers to have both cytotoxicity and antimetastatic property as designed. Although the complex has comparable cytotoxicities to cisplatin in tested cancer cell lines, this prodrug selectively kills cancer but not normal cells, and the IC values of the Pt(IV)-Ru(II) complex are 7-10 times higher than those of cisplatin toward normal cells. The cancer cell selectivity is further demonstrated by a cancer-normal cell coculture system. In addition, the antimetastatic properties of the heterodinuclear complex are assessed by using highly metastatic human breast cancer cells, and the results show that the migration and invasion of cancer cells are effectively restrained after the treatment. Moreover, the Pt(IV)-Ru(II) complex displays lower toxicity than cisplatin in developing zebrafish embryos. We, therefore, report an example of heterodinuclear Pt(IV)-Ru(II) complex not only to defeat both drug resistance and cancer metastasis but also having significantly improved cancer cell selectivity and reduced in vivo toxicity than cisplatin.

Three pairs of enantiomers bearing mitochondria‐targeted TPP+ groups as potential anti‐cancer agents

“…The developing of the targeted drugs led to the improvement on the treatment efficiency and the decrease of some side effects . Some traditional drugs has been applied for the field of anticancer treatments, such as cisplatin, carboplatin, and oxaliplatin .…”

Two groups of copperII pyridine–triazole complexes with “open or close” pepper rings and their in vitro antitumor activities

“…1 Therefore, many attempts have been made to nd more effective and less toxic alternative metal-based drugs to cisplatin. [2][3][4][5][6] Among the nonplatinum drugs, copper-based complexes have gained increasing attention owing to the diverse fascinating biological analogue ligands that can be linked to the metal centre in its different binding modes. 7 Besides the metal itself, the ligand is very important in regulating the activity of the complex; even the partial modication of the ligand's structure may play a crucial role in the biological activity.…”

A Dy(iii)–organic framework as a fluorescent probe for highly selective detection of picric acid and treatment activity on human lung cancer cells

“…In modern medicine, metal ions and their complexes have been used for decades [1]. Cisplatin is an effective cancer drug and its discovery promotes the development of inorganic chemistry of drugs.…”